Licensed Combination Products definition

Licensed Combination Products means pharmaceutical compositions comprised of the Compound as a therapeutically active ingredient in combination with other active ingredients and which uses or is developed or manufactured using or in connection with the Supernus Intellectual Property.
Sample 1Sample 2Sample 3
Licensed Combination Products means pharmaceutical combinations and compositions that have been prepared and are in a tablet form containing 50mg of DTG Compound ready for administration to Adult Patients solely for antiretroviral therapy for HIV/AIDS which contain the DTG Compound as an active ingredient in combination with (a) the ABC Compound and/or (b) other active ingredients (subject to the limitation set out in Clause 2.9) and in each case where the resulting combination product has been recommended by the World Health Organisation or the United States Department of Health and Human Services, in each case for supply to and use by Adult Patients.
Sample 1
Licensed Combination Products means any product that is comprised in part of a Licensed Product and in part of one or more other biologically active diagnostic, preventive or therapeutic agents which are not themselves Licensed Products (the "Other Agents"). "Other Agents" excludes diluents and vehicles of Licensed Products.
Sample 1

Examples of Licensed Combination Products in a sentence

  • Subject to the terms and conditions contained in this Agreement, and in consideration of the rights granted by Supernus hereunder, United Therapeutics shall pay Supernus, or an Affiliate of Supernus designated in writing, the following Milestone Payments as pertaining to the development of Licensed Products or Licensed Combination Products for a second indication, contingent upon the occurrence of the corresponding specified contingent Milestone Event detailed below.

  • Following First Commercial Sale in any country, United Therapeutics shall have the right to distribute (without receipt of compensation and without payment of a royalty to Supernus) in any calendar year for compassionate purposes to indigent patients, an aggregate of up to [**] ([**]%) of the total number of Licensed Products or Licensed Combination Products sold in units (with the receipt of compensation) in such country in such calendar year by United Therapeutics, its Affiliates and Sub-Licensees.

  • For the sake of clarity, Sanofi-Aventis shall be entitled to make, have made, use, sell, have sold, develop or have developed Licensed Combination Products in the U.S. Territory after the end of the Exclusivity Term, subject to the last sentence of Section 8.2(c).

  • Save as provided above, we may terminate the Service at any time at our discretion with reasonable notice.

  • Company shall keep, and shall require sublicensees to keep accurate and correct records of Licensed Products, Licensed Combination Products or Licensed Processes or Services made, used or sold under this Agreement, appropriate to determine the amount of royalties due hereunder to University.

  • Upon termination of this Agreement under this Article XII, but subject to the provisions of Article XII Section G, Company shall either return to University Licensed Products or Licensed Combination Products in its possession or certify to University in writing that Licensed Products or Licensed Combination Products in its possession have been destroyed.

  • Company and any sublicensee thereof may, however, after the effective date of such termination, have six (6) months to sell all Licensed Product or Licensed Combination Products completed and in inventory.

  • United Therapeutics shall, and shall procure that its Affiliates and Sub-Licensees shall, use reasonable commercial efforts to develop and commercialize Licensed Products and Licensed Combination Products.

  • Company shall use its best efforts, consistent with sound and reasonable business practices and judgment, to effect commercialization of Licensed Products, Licensed Combination Products, Licensed Processes or Services as soon as practicable and to maximize these sales.

  • No royalties shall be payable on Licensed Products or Licensed Combination Products distributed to Third Parties without the receipt of compensation solely as a sample for testing or evaluation purposes.


More Definitions of Licensed Combination Products

Licensed Combination Products means pharmaceutical combinations and compositions that have been prepared and are in a tablet form containing 50mg of DTG Compound ready for administration to Adult Patients solely for antiretroviral therapy for HIV/AIDS which contain the DTG Compound as an active ingredient in combination with (a) the ABC Compound and/or (b) other active ingredients (subject to the limitation set out in Clause 2.9) and in each case where the resulting combination product has been recommended by the World Health Organisation for supply to and use by Adult Patients.
Sample 1
Licensed Combination Products has the meaning given to such term in the Sublicence;
Sample 1

Related to Licensed Combination Products

  • Combination Products means COBI Combination Products, EVG Combination Products, TDF Combination Products, TAF Combination Products and Quad Product.

  • Combination Product means any combination of the Product with one (1) or more other active ingredients, products or services that is not the Product, where such products are sold either as a fixed dose/unit or as separate doses/units in a single package for a single price.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Licensed Compound means [***].

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Competing Product means [***].

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Bundled Product means Product sold together with any other product(s) or service(s) at a single unit price, whether packaged together or separately, and which other product(s) or service(s) have material independent value from Product itself.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Hemp products means all products made from industrial hemp,

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Licensed producer means an agent, broker, or reinsurance intermediary licensed pursuant to the applicable provision of the insurance law of any jurisdiction.

  • Spray buff product means a product designed to restore a worn floor finish in conjunction with a floor buffing machine and special pad.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Licensed Field means [***].

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.